Market Closed -
Other stock markets
|
Pre-market 07:20:34 am | |||
8.685 USD | -20.61% | 10.08 | +16.06% |
12:04pm | Summit Therapeutics Generates $200 Million Through Share Sale; Expand License Territories for Ivonescimab | MT |
May. 31 | Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+232.76% | 6.1B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.61% | 21.96B | |
-9.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- SMMT Stock
- News Summit Therapeutics Inc.
- Transcript : Summit Therapeutics plc, Q2 2020 Earnings Call, Oct 11, 2019